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To investigate the mechanism of 
resistance in the isolates, fragments of 
gyrA (847 bp) and parC (822 bp) genes 
were ampliﬁ  ed by using primers gyrA-
1F (5′-gttttcccagtcacgacgttgtaATGA
CCGACGCAACCATCCGCCAC-3′) 
and gyrA-1R (5′-ttgtgagcggataacaattt
cCCAGCTTGGCTTTGTTGACCTG
ATAG-3′), and parC-1F (5′-gttttcccag
tcacgacgttgtaATGAATACGCAAGC
GCACGCCCCA-3′) and parC-1R (5′- 
ttgtgagcggataacaatttcGGAATTGGC
GTTCGGCGGCAGCTC-3′), respec-
tively (sequences in lower case letters 
are adaptors for universal forward and 
reverse sequences were added for se-
quencing after ampliﬁ  cation).  Prim-
ers used for ampliﬁ  cation of the parE 
gene were as described (8).
Sequencing of fragments of 
gyrA, parC, and parE genes showed 
a mutation in the gyrA gene in the 3 
Cip-R isolates resulting in a Thr91 → 
Ile substitution. Cip-R1 also showed 
additional alterations of Asn103 → 
Asp, Ile111 → Val, and Val120 → Ile, 
which were described for meningo-
coccal isolates (3). Sequences of parC 
and parE genes were the same as in 
a ciproﬂ  oxacin-susceptible  isolate 
tested. The association of the Cip-R 
phenotype with mutations in gyrA was 
conﬁ  rmed by transformation into the 
susceptible isolate by using appropri-
ate PCR products (9). In addition to 
the common Thr91 → Ile substitution, 
the 3 Cip-R isolates were distinguish-
able by additional gyrA alterations or 
phenotypic and genotypic character-
istics. This ﬁ  nding suggests indepen-
dent events and argues against clonal 
expansion of Cip-R meningococci.
Serogroup A meningococcal iso-
lates in France are rare and mostly 
imported. Lack of detection of cip-
roﬂ  oxacin resistance among African 
isolates tested in this study may be 
caused by the relatively low number 
of these isolates (n = 246). Therefore, 
surveillance of antimicrobial drug 
susceptibility of meningococcal iso-
lates should be enhanced by using 
molecular approaches that can also 
be used as nonculture techniques. 
This molecular approach will be use-
ful in countries with limited access to 
classic microbiologic culture–based 
methods. Reports of invasive cases 
caused by W-135 Cip-R meningo-
cocci should alert physicians who 
use quinolones to treat respiratory 
infections in elderly persons. This 
age group is affected most often by 
invasive meningococcal pneumonia 
and 54.5% of such cases are caused 
by W-135 meningococci (10).
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Rare 
Cryptosporidium 
hominis Subtype 
Associated with 
Aquatic Center Use
To the Editor: Cryptosporidiosis 
is the most frequently reported gas-
trointestinal illness in outbreaks as-
sociated with treated (disinfected) 
recreational water venues in the Unit-
ed States (1). In 2003, an increased 
number of cryptosporidiosis cases 
occurred in the Tri-Cities area of the 
Lower Mainland region (near Van-
couver), in British Columbia, Canada. 
Although all cases were associated 
with the use of a community aquatic 
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center, their onset dates were spread 
over a 3-month period, and the link 
between cases was unclear. The aim 
of this study was to determine if the 
cases in this disease cluster were relat-
ed. Although suitable molecular mark-
ers had yet to be deﬁ  ned at the time 
of the outbreak, recent reports on the 
use of the gp60 gene for subtyping in 
molecular epidemiologic studies (2,3) 
have enabled us to reanalyze the iso-
lates and report these results.
Fifteen laboratory-conﬁ  rmed cas-
es were identiﬁ  ed from October 15 to 
December 5, 2003. This number was in 
excess of the anticipated incidence rate 
for this community, which averaged 5 
reported cryptosporidiosis cases per 
year. During the period of investiga-
tion, an incident of fecal contamination 
at the aquatic center on October 10, 
2003, was documented and remediation 
involved increasing the free chlorine 
concentration. Because the regional 
health authority was concerned about 
the increased number of cases, the fa-
cility closed voluntarily on December 
5 for further remediation. However, 
recorded free chlorine concentrations 
did not exceed 2.0 ppm at any time 
during the investigative period (Octo-
ber 5–December 31).
The health authority released a 
public advisory encouraging those who 
used the facility to submit fecal speci-
mens for laboratory testing. The health 
authority also sent letters to family 
physicians in the area, informing them 
of the disease cluster and requesting 
that unpreserved stool specimens be 
collected, in addition to the formalin-
ﬁ  xed specimens, for routine diagnos-
tic testing. Nine fecal specimens were 
collected from clinically symptomatic 
case-patients with histories of exposure 
to the implicated aquatic center. Five 
specimens were selected by using the 
criteria that they were from patients 
with laboratory-conﬁ  rmed  cryptospo-
ridiosis cases from 5 separate house-
holds. The specimens were then coded 
for anonymity before subsequent mo-
lecular analysis. Genomic DNA was ex-
tracted from puriﬁ  ed Cryptosporidium 
oocysts by freeze-thawing, and the spe-
cies was determined by PCR ampliﬁ  ca-
tion and sequencing of the 18S rRNA 
gene as described previously (4). The 
gp60 gene was also ampliﬁ  ed by PCR 
by using primers described by Ong and 
Isaac-Renton (5). DNA sequences of 
amplicons were determined by cycle 
sequencing and assembled as described 
previously (4,5). The gp60 allele and 
subtype were identiﬁ   ed by multiple 
sequence alignment with GenBank 
reference sequences and phylogenetic 
analysis that used ClustalX version 1.8 
(www.clustal.org) as well as manual 
quantiﬁ  cation of microsatellite repeats.
The 18S rRNA and gp60 genes 
were ampliﬁ   ed successfully from 4 
specimens. On the basis of the 18S 
rRNA gene sequence, all case-patients 
were infected with Cryptosporidium 
hominis, a species associated primar-
ily with human-to-human transmis-
sion. The gp60 sequences from all 4 
case-patients were identical and were 
subtype IdA19, a rarely reported sub-
type of C. hominis. Globally, most 
reports of the gp60 Id allele, such as 
9 reported cases from Australia, have 
identiﬁ  ed the IdA15G1 subtype (3). 
Another subtype, IdA18, was isolated 
from 5 case-patients in a 1997 food-
borne outbreak in Spokane, Washing-
ton (6). To date, the IdA19 subtype 
has been identiﬁ  ed in only 1 sporadic 
case, in northern Ontario (7), and a 
subset of cases (seven 1dA19 and 2 
mixed IdA19 and IbA10G2) in the 
2001 waterborne outbreak in North 
Battleford, Saskatchewan (5,8). The 
IdA19 subtype is identical in se-
quence to the IdA18 subtype except 
for 1 extra TCA repeat in the micro-
satellite region. Neither subtype has 
been reported anywhere in the world 
except in Canada and the Paciﬁ  c 
Northwest.
Because cases from all previous 
C. hominis outbreaks of cryptospori-
diosis in British Columbia have been 
caused by the IbA10G2 subtype, the 
most prevalent subtype in sporadic 
and outbreak cases around the world 
(2,5,9,10), our results indicate the 
presence of a new subpopulation of 
C. hominis parasites that could cause 
future disease outbreaks. The iden-
tiﬁ  cation of the same subtype in all 4 
case-patients with cryptosporidiosis as-
sociated with the use of a community 
aquatic center was consistent with their 
exposure history and conﬁ  rmed that all 
cases were linked epidemiologically. 
However, the association between the 
single northern Ontario sporadic case 
and the larger number of Saskatch-
ewan and British Columbia outbreak 
cases is uncertain. The association with 
the IdA18 subtype in the Washington 
foodborne outbreak is also unknown. 
Further research is needed to determine 
the distribution and prevalence of gp60 
subtypes in Canada as well as other 
parts of the world before we can more 
clearly understand the transmission of 
the IdA19 subtype.
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Two Imported 
Chikungunya 
Cases, Taiwan
To the Editor: Chikungunya is 
a reemerging infectious disease, en-
demic to Africa and Southeast Asia, 
caused by a mosquito-borne alphavi-
rus in the family Togaviridae. Numer-
ous chikungunya outbreaks have been 
reported in Africa and Southeast Asia 
since chikungunya virus (CHIKV) 
was ﬁ  rst isolated in Tanzania in 1953 
(1). Since 2005, several Indian Ocean 
islands and India have experienced 
massive CHIKV outbreaks caused by 
the East/Central/South African geno-
type (2,3), whereas all earlier isolates 
from India during 1963–1973 were of 
the Asian genotype (4). Other chikun-
gunya outbreaks caused by the Asian 
genotype were frequently reported 
during 1960–2003 in many Southeast 
Asian countries, including India, Ma-
laysia, Indonesia, Cambodia, Vietnam, 
Myanmar, Pakistan, the Philippines, 
and Thailand. Epidemics caused by 
reemerging CHIKV were reported in 
Indonesia and Malaysia during 2005–
2007 (1,5).
We have previously reported on 
fever screening at airports in Taiwan 
as part of active surveillance for a 
panel of notiﬁ  able infectious diseases 
such as dengue, gastroenteritis caused 
by enteric bacteria, malaria, and yel-
low fever (6). The activity is carried 
out by using infrared thermal scan-
ners to measure the body temperature 
of arriving passengers. Diagnostic 
testing algorithms for patients be-
ing screened for fever were based on 
evaluation by airport clinicians. The 
rationale behind this process is to 
minimize local outbreaks by reduc-
ing the number of imported cases. We 
report 2 imported chikungunya case-
patients identiﬁ  ed in Taiwan by fever 
screening at airports; 1 had returned 
from Singapore in 2006, infected with 
CHIKV East/Central/South African 
genotype, and the other had returned 
from Indonesia in 2007, infected with 
the Asian genotype.
To assess viremic fever patients 
with alphavirus infection, a multiplex 
1-step SYBR Green I-based real-time 
reverse transcription–PCR (RT-PCR) 
was developed. A cocktail consist-
ing of 3 sets of primers was mixed 
and used for RT-PCR screening. The 
alphavirus-speciﬁ  c primer set (AL-2: 
5′-AAG CTY CGC GTC CTT TAC 
CAA AG-3′ and AL-3: 5′-GTG GTG 
TCA AAC CCT ATC CA-3′) targeted 
a consensus region of the nonstruc-
tural protein 1 (nsp1) genes to detect 
all alphaviruses. The CHIKV-speciﬁ  c 
primer set (F-CHIK: 5′-AAG CTY 
CGC GTC CTT TAC CAA AG-3′ 
and R-CHIK: 5′-CCA AAT TGT 
CCY GGT CTT CCT-3′) targeted a 
region of the envelope protein 1 (E1) 
gene of CHIKVs (7). The Ross River 
virus–speciﬁ  c primer set (RRV-1: 5′-
GGG TAG AGA GAA GTT YGT 
GGT YAG-3′ and RRV-2: 5′-CGG 
TAT ATC TGG YGG TGT RTG C-3′) 
targeted a region of the envelope pro-
tein 2 (E2) gene of Ross River virus. 
Positive results were then conﬁ  rmed 
by gene sequence analysis, virus iso-
lation, and serologic tests. The nucle-
otide sequences of complete structural 
polyprotein genes were determined as 
previously described and submitted to 
GenBank (accession nos. EU192142 
and EU192143) (3,8). A phylogenetic 
tree, based on a total of 23 CHIKV 
partial E1 gene sequences (255 bp), 
was drawn to trace the origin of 2 
CHIKV isolates reported in this study 
(Figure).
The initial imported chikungunya 
case was detected at Taiwan Taoyuan 
International Airport on November, 
20, 2006, in a 13-year-old Taiwanese 
boy who was returning from studying 
at an international educational train-
ing center in Singapore. The second 
imported case was also detected at 
Taiwan Taoyuan International Airport 
on June, 20, 2007, in a 5-year-old boy 
on his return from visiting relatives in 
East Kalimantan Province, Indonesia, 
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